Zivo Bioscience, Inc. (ZIVO)
6.50
-0.01
(-0.21%)
USD |
OTCM |
Oct 16, 16:00
Zivo Bioscience Max Drawdown (5Y) : 99.41% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.41% |
| August 31, 2026 | 99.41% |
| July 31, 2026 | 99.41% |
| June 30, 2026 | 99.41% |
| May 31, 2026 | 99.41% |
| April 30, 2026 | 99.41% |
| March 31, 2026 | 99.41% |
| February 28, 2026 | 99.41% |
| January 31, 2026 | 99.41% |
| December 31, 2025 | 99.41% |
| November 30, 2025 | 99.41% |
| October 31, 2025 | 99.41% |
| September 30, 2025 | 99.41% |
| August 31, 2025 | 99.41% |
| July 31, 2025 | 99.41% |
| June 30, 2025 | 99.41% |
| May 31, 2025 | 99.41% |
| April 30, 2025 | 99.41% |
| March 31, 2025 | 99.41% |
| February 28, 2025 | 99.41% |
| January 31, 2025 | 99.41% |
| December 31, 2024 | 99.41% |
| November 30, 2024 | 99.41% |
| October 31, 2024 | 99.41% |
| September 30, 2024 | 99.41% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.41% |
| July 31, 2024 | 99.41% |
| June 30, 2024 | 99.41% |
| May 31, 2024 | 99.41% |
| April 30, 2024 | 99.41% |
| March 31, 2024 | 99.41% |
| February 29, 2024 | 99.41% |
| January 31, 2024 | 99.41% |
| December 31, 2023 | 99.41% |
| November 30, 2023 | 99.41% |
| October 31, 2023 | 96.81% |
| September 30, 2023 | 91.44% |
| August 31, 2023 | 88.43% |
| July 31, 2023 | 88.09% |
| June 30, 2023 | 85.39% |
| May 31, 2023 | 84.66% |
| April 30, 2023 | 84.66% |
| March 31, 2023 | 84.66% |
| February 28, 2023 | 84.66% |
| January 31, 2023 | 84.66% |
| December 31, 2022 | 86.14% |
| November 30, 2022 | 86.14% |
| October 31, 2022 | 87.13% |
| September 30, 2022 | 87.13% |
| August 31, 2022 | 87.88% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| PMGC Holdings, Inc. | -- |
| Shonghoya Intl Group, Inc. | 99.30% |
| TFA Therapeutics, Inc. | -- |
| Arcadia Biosciences, Inc. | 99.73% |
| CCA Industries, Inc. | 91.78% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -42.06 |
| Beta (5Y) | 0.3782 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 247.7% |
| Historical Sharpe Ratio (5Y) | -0.1545 |
| Historical Sortino (5Y) | -0.6295 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.26% |